Search - tctmd.com

Displaying 161 - 180 of 213

Sort: Relevancy | Date

News Daily News

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

December 14, 2014

News Daily News

Small OCT Study Suggests Favorable Long-term Response to Bioresorbable Scaffold

December 04, 2014

News Daily News

对STEMI使用生物可吸收支架的立即、中期结果令人鼓舞

November 17, 2014

News Daily News

Los Resultados Inmediatos y a Medio Plazo son Esperanzadores para los Andamiajes Bioabsorbibles en el Manejo de STEMI

November 17, 2014

News Daily News

Immediate, Midterm Outcomes Encouraging for Bioresorbable Scaffolds in STEMI

November 17, 2014

News Daily News

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

November 17, 2014

News Conference News TCT 2014

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

September 17, 2014

News Industry News

New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents

September 16, 2014

News Conference News TCT 2014

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

September 15, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

News Conference News TCT 2014

ABSORB EXTEND: BVS Safe Out to 3 Years

September 14, 2014

News Conference News TCT 2014

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

September 13, 2014

News Conference News ESC 2014

PROTECT: ZES Sustain Lead Over SES at 5 Years

September 03, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

July 24, 2014

News Daily News

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

June 04, 2014

News Industry News

Elixir Medical Announces Outstanding Long-term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE Mark-approved Novolimus Eluting Coronary Intervention Systems

May 23, 2014

News Industry News

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

May 13, 2014

News Daily News

Bioresorbable Scaffold Performs Well in Select STEMI Patients

January 22, 2014

News Daily News

Bioresorbable Scaffold Designed for PAD Yields Good Early Results

January 22, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.